Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy
Authors
Keywords
-
Journal
Pharmaceutics
Volume 13, Issue 4, Pages 520
Publisher
MDPI AG
Online
2021-04-12
DOI
10.3390/pharmaceutics13040520
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
- (2021) Eryn Blass et al. Nature Reviews Clinical Oncology
- Synthetic HDL Nanoparticles Delivering Docetaxel and CpG for Chemoimmunotherapy of Colon Adenocarcinoma
- (2020) Lindsay M. Scheetz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Doxil chemotherapy plus liposomal P5 immunotherapy decreased myeloid-derived suppressor cells in murine model of breast cancer
- (2020) Jamshid Gholizadeh Navashenaq et al. Nanomedicine-Nanotechnology Biology and Medicine
- Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
- (2020) John D. Martin et al. Nature Reviews Clinical Oncology
- Codelivery of Anti‐PD‐1 Antibody and Paclitaxel with Matrix Metalloproteinase and pH Dual‐Sensitive Micelles for Enhanced Tumor Chemoimmunotherapy
- (2020) Zhenwei Su et al. Small
- CCL2 and CXCL12 Derived from Mesenchymal Stromal Cells Cooperatively Polarize IL-10+ Tissue Macrophages to Mitigate Gut Injury
- (2020) Jayeeta Giri et al. Cell Reports
- Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
- (2020) Isaure Vanmeerbeek et al. OncoImmunology
- Nano Codelivery of Oxaliplatin and Folinic Acid Achieves Synergistic Chemo-Immunotherapy with 5-Fluorouracil for Colorectal Cancer and Liver Metastasis
- (2020) Jianfeng Guo et al. ACS Nano
- Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
- (2020) Lorenzo Galluzzi et al. Journal for ImmunoTherapy of Cancer
- Co-delivery of doxorubicin and epacadostat via heparin coated pH-sensitive liposomes to suppress the lung metastasis of melanoma
- (2020) Yi Chen et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Evaluation of cell surface reactive immuno-adjuvant in combination with immunogenic cell death inducing drug for in situ chemo-immunotherapy
- (2020) Adam A. Walters et al. JOURNAL OF CONTROLLED RELEASE
- Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor therapy
- (2020) Parvin Zamani et al. LIFE SCIENCES
- Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
- (2020) Lorenzo Galluzzi et al. Nature Reviews Clinical Oncology
- A decade of immune-checkpoint inhibitors in cancer therapy
- (2020) Caroline Robert Nature Communications
- Thermosensitive Exosome–Liposome Hybrid Nanoparticle‐Mediated Chemoimmunotherapy for Improved Treatment of Metastatic Peritoneal Cancer
- (2020) Qijun Lv et al. Advanced Science
- Liposomal Delivery of Mitoxantrone and a Cholesteryl Indoximod Prodrug Provides Effective Chemo-immunotherapy in Multiple Solid Tumors
- (2020) Kuo-Ching Mei et al. ACS Nano
- Oxaliplatin-/NLG919 prodrugs-constructed liposomes for effective chemo-immunotherapy of colorectal cancer
- (2020) Fengyun Shen et al. BIOMATERIALS
- Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression
- (2020) Astrid De Boeck et al. Nature Communications
- Neoadjuvant Use of Oncolytic Herpes Virus G47Δ Enhances the Antitumor Efficacy of Radiofrequency Ablation
- (2020) Tomoharu Yamada et al. Molecular Therapy-Oncolytics
- Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity
- (2020) Jingjing Liang et al. Science Advances
- Tumor repolarization by an advanced liposomal drug delivery system provides a potent new approach for chemo-immunotherapy
- (2020) L. Ringgaard et al. Science Advances
- Immune Checkpoint Blockade Improves Chemotherapy in the PyMT Mammary Carcinoma Mouse Model
- (2020) Evelyn Sirait-Fischer et al. Frontiers in Oncology
- Anti-PD-L1 mediating tumor-targeted codelivery of liposomal irinotecan/JQ1 for chemo-immunotherapy
- (2020) Zhi-di He et al. ACTA PHARMACOLOGICA SINICA
- Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression
- (2020) Irene Y. Cheung et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy
- (2020) Megan M. Tu et al. Communications Biology
- Dual-targeting tumor cells and tumor associated macrophages with lipid coated calcium zoledronate for enhanced lung cancer chemoimmunotherapy
- (2020) Xinlong Zang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Novel nanotechnology approaches for diagnosis and therapy of breast, ovarian and cervical cancer in female: A review
- (2020) Ameeduzzafar Zafar et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Tumor-Targeted Chemoimmunotherapy with Immune-Checkpoint Blockade for Enhanced Anti-Melanoma Efficacy
- (2019) Man Li et al. AAPS Journal
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Nanoparticle‐Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions
- (2019) Jianping Liu et al. Small
- Current State of Immunotherapy for Treatment of Glioblastoma
- (2019) Tresa McGranahan et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- High-Density Lipoprotein-Mimicking Nanodiscs for Chemo-immunotherapy against Glioblastoma Multiforme
- (2019) Padma Kadiyala et al. ACS Nano
- Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
- (2019) Alessandra Lopes et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Combining activatable nanodelivery with immunotherapy in a murine breast cancer model
- (2019) Azadeh Kheirolomoom et al. JOURNAL OF CONTROLLED RELEASE
- Nanoenabled Reversal of IDO1-Mediated Immunosuppression Synergizes with Immunogenic Chemotherapy for Improved Cancer Therapy
- (2019) Hua Huang et al. NANO LETTERS
- Programmed death-ligand 1 monoclonal antibody-linked immunoliposomes for synergistic efficacy of miR-130a and oxaliplatin in gastric cancers
- (2019) Fengyong Wang et al. Nanomedicine
- Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunity
- (2019) Heng Yang et al. NATURE MEDICINE
- ATIM-14. RESULTS OF PHASE II CLINICAL TRIAL OF ONCOLYTIC HERPES VIRUS G47Δ IN PATIENTS WITH GLIOBLASTOMA
- (2019) Tomoki Todo NEURO-ONCOLOGY
- Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages
- (2019) Emeric Limagne et al. Cancer Immunology Research
- T-cell Dysfunction in Glioblastoma: Applying a New Framework
- (2018) Karolina I. Woroniecka et al. CLINICAL CANCER RESEARCH
- Current challenges for cancer vaccine adjuvant development
- (2018) William S. Bowen et al. Expert Review of Vaccines
- Temozolomide loaded nano lipid based chitosan hydrogel for nose to brain delivery: Characterization, nasal absorption, histopathology and cell line study
- (2018) Anam Khan et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer
- (2018) Anne Rodallec et al. International Journal of Nanomedicine
- First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
- (2018) Linda M. Liau et al. Journal of Translational Medicine
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
- (2018) Rui Kuai et al. Science Advances
- Immune lipoprotein nanostructures inspired relay drug delivery for amplifying antitumor efficiency
- (2018) Yue Han et al. BIOMATERIALS
- Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1- profile in a TLR4-dependent manner
- (2018) Carlos W Wanderley et al. CANCER RESEARCH
- Nanotechnology-mediated immunochemotherapy combined with docetaxel and PD-L1 antibody increase therapeutic effects and decrease systemic toxicity
- (2018) Zili Gu et al. JOURNAL OF CONTROLLED RELEASE
- Reprogramming human T cell function and specificity with non-viral genome targeting
- (2018) Theodore L. Roth et al. NATURE
- Chemo-immunotherapy of colon cancer with focused ultrasound and Salmonella-laden temperature sensitive liposomes (thermobots)
- (2018) Kalyani Ektate et al. Scientific Reports
- Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway
- (2018) Jianqin Lu et al. ACS Nano
- Cocktail Strategy Based on Spatio-Temporally Controlled Nano Device Improves Therapy of Breast Cancer
- (2018) Tianqun Lang et al. ADVANCED MATERIALS
- Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial
- (2018) S. A. Toms et al. JOURNAL OF NEURO-ONCOLOGY
- CXCL16/CXCR6 Axis Drives Microglia/Macrophages Phenotype in Physiological Conditions and Plays a Crucial Role in Glioma
- (2018) Francesca Lepore et al. Frontiers in Immunology
- Immune microenvironment of gliomas
- (2017) Anna Gieryng et al. LABORATORY INVESTIGATION
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape
- (2017) Abhishek D. Garg et al. TRENDS IN IMMUNOLOGY
- Cytokines in Cancer Immunotherapy
- (2017) Thomas A. Waldmann Cold Spring Harbor Perspectives in Biology
- Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
- (2017) Martin Lauss et al. Nature Communications
- Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency
- (2017) Miao Kong et al. Theranostics
- Harnessing the properties of dendritic cells in the pursuit of immunological tolerance
- (2017) Christopher Horton et al. Biomedical Journal
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells
- (2016) Alan L. Chang et al. CANCER RESEARCH
- Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemoimmunotherapy
- (2016) Bradley J. Monk et al. CLINICAL CANCER RESEARCH
- Coencapsulation of alendronate and doxorubicin in pegylated liposomes: a novel formulation for chemoimmunotherapy of cancer
- (2016) Hilary Shmeeda et al. JOURNAL OF DRUG TARGETING
- Brain Targeting of Temozolomide via the Intranasal Route Using Lipid-Based Nanoparticles: Brain Pharmacokinetic and Scintigraphic Analyses
- (2016) Anam Khan et al. MOLECULAR PHARMACEUTICS
- Designer vaccine nanodiscs for personalized cancer immunotherapy
- (2016) Rui Kuai et al. NATURE MATERIALS
- The cancer vaccine resurgence
- (2016) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles
- (2015) Srinivas Ramishetti et al. ACS Nano
- CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice
- (2015) Yunching Chen et al. HEPATOLOGY
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity
- (2015) Virgil E.J.C. Schijns et al. VACCINE
- RNA-Based Vaccines in Cancer Immunotherapy
- (2015) Megan A. McNamara et al. Journal of Immunology Research
- Combinatorial Strategies for the Induction of Immunogenic Cell Death
- (2015) Lucillia Bezu et al. Frontiers in Immunology
- Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites
- (2015) Powell Perng et al. Frontiers in Oncology
- Immunoliposome co-delivery of bufalin and anti-CD40 antibody adjuvant induces synergetic therapeutic efficacy against melanoma
- (2014) Wei Cao et al. International Journal of Nanomedicine
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer
- (2014) K. Odunsi et al. Cancer Immunology Research
- CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy
- (2013) Yuting Ma et al. CANCER RESEARCH
- Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice
- (2013) Yunching Chen et al. HEPATOLOGY
- MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
- (2013) P. Leone et al. JNCI-Journal of the National Cancer Institute
- Enhanced Antitumor Response Mediated by the Codelivery of Paclitaxel and Adenoviral Vector Expressing IL-12
- (2013) Linjie Cao et al. MOLECULAR PHARMACEUTICS
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
- (2013) N. Iida et al. SCIENCE
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- Chemoimmunotherapy Using Pegylated Liposomal Doxorubicin and Interleukin-18 in Recurrent Ovarian Cancer: A Phase I Dose-Escalation Study
- (2013) F. Simpkins et al. Cancer Immunology Research
- Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo
- (2012) Miki Tongu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival
- (2012) D. A. Wainwright et al. CLINICAL CANCER RESEARCH
- Developing mRNA-vaccine technologies
- (2012) Thomas Schlake et al. RNA Biology
- Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
- (2012) J. Scholler et al. Science Translational Medicine
- Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
- (2011) R. J. Brentjens et al. BLOOD
- Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy
- (2011) Xian-Zhu Yang et al. JOURNAL OF CONTROLLED RELEASE
- Low-Dose Cyclophosphamide Selectively Decreases Regulatory T Cells and Inhibits Angiogenesis in Dogs with Soft Tissue Sarcoma
- (2011) J.H. Burton et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA vaccines: an historical perspective and view to the future
- (2010) Margaret A. Liu IMMUNOLOGICAL REVIEWS
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transcriptional complexes formed by NFAT dimers regulate the induction of T cell tolerance
- (2009) Noemi Soto-Nieves et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Natural Killer Cell Accumulation in Tumors Is Dependent on IFN- and CXCR3 Ligands
- (2008) M. Wendel et al. CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started